scholarly article | Q13442814 |
P953 | full work available at URL | http://intl.jbc.org/cgi/content/abstract/254/12/5357 |
P698 | PubMed publication ID | 447655 |
P2093 | author name string | T. S. Edgington | |
E. F. Plow | |||
G. A. Marguerie | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 7 | |
P304 | page(s) | 5357-5363 | |
P577 | publication date | 1979-06-01 | |
1979-06-25 | |||
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Human platelets possess an inducible and saturable receptor specific for fibrinogen | |
P478 | volume | 254 |
Q33821916 | A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa |
Q35807990 | A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein |
Q42161870 | A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom |
Q37004238 | A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors |
Q36529569 | Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells |
Q36233226 | Affinity modulation of integrin alpha 5 beta 1: regulation of the functional response by soluble fibronectin |
Q36772797 | Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor |
Q73295898 | Affinity of Fibrinogen Binding to Platelet Membrane Glycoprotein IIb/IIIa Increases with RGDS and gamma Chain Fibrinogen Peptide Hybrid |
Q34313515 | Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation |
Q36529134 | An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion |
Q39989355 | Analysis of Fyn function in hemostasis and alphaIIbbeta3-integrin signaling |
Q24561798 | Association of the low molecular weight GTP-binding protein rap2B with the cytoskeleton during platelet aggregation |
Q37357899 | Bcr/Abl expression stimulates integrin function in hematopoietic cell lines |
Q40919205 | Binding of fibrinogen to human monocytes |
Q35593515 | Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa |
Q41517642 | Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes |
Q42861864 | Calcium binding to human platelet integrin GPIIb/IIIa and to its constituent glycoproteins. Effects of lipids and temperature |
Q40141187 | Characteristics of an ADP receptor mediating platelet activation |
Q36426462 | Characterization of the 5'-flanking region for the human fibrinogen beta gene |
Q42701284 | Comparative pharmacology of analogues of S‐nitroso‐N‐acetyl‐dl‐penicillamine on human platelets |
Q37007168 | Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen |
Q36985923 | Complex formation of platelet thrombospondin with fibrinogen |
Q41146492 | Description of an in vitro angiogenesis model designed to test antiangiogenic molecules |
Q36220809 | Differential structural requirements for fibrinogen binding to platelets and to endothelial cells |
Q34543964 | Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia |
Q34018917 | Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation |
Q35585012 | Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon |
Q34173198 | Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow |
Q77763145 | Elucidation of a common structure of selective fibrinogen receptor antagonists |
Q41438052 | Endocytosis by human platelets: metabolic and freeze-fracture studies |
Q36232933 | Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets |
Q34526333 | Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase |
Q41563619 | Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). |
Q36524428 | Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet function. |
Q40343677 | Expression, topography, and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin |
Q34554656 | Fibrin induces release of von Willebrand factor from endothelial cells |
Q36316463 | Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro |
Q36216126 | Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro. |
Q37397492 | Fibrinogen mitogenic effect on hemopoietic cell lines: control via receptor modulation |
Q35587275 | Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation |
Q39800614 | Functional assay of antiplatelet drugs based on margination of platelets in flowing blood |
Q37360713 | Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection |
Q36218390 | Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets |
Q36220256 | High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets |
Q36348940 | Human platelet activation by C3a and C3a des-arg |
Q37394914 | Immunologic relationship between platelet membrane glycoprotein GPIIb/IIIa and cell surface molecules expressed by a variety of cells |
Q36299694 | Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline |
Q37609861 | Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody |
Q73254319 | Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction |
Q37393216 | Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets |
Q37011736 | Integrin αIIbβ3: from discovery to efficacious therapeutic target |
Q34521582 | Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding |
Q34624945 | Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation |
Q41848646 | Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets |
Q70988269 | Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG |
Q42874602 | Interactions between platelet-surface glycoproteins. Identification of glycoproteins capable of binding to platelet surfaces |
Q42981591 | Interactions of integrin GPIIb/IIIa-derived peptides with fibrinogen investigated by NMR spectroscopy |
Q37026661 | Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody |
Q24314835 | Isolation of the thrombospondin membrane receptor |
Q37008359 | Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway |
Q68585030 | Localization of adhesive proteins in two newly subdivided zones in electron-lucent matrix of human platelet alpha-granules |
Q35836105 | Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses |
Q49251166 | Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis |
Q70159564 | Microenvironment changes of human blood platelet membranes associated with fibrinogen binding |
Q34574739 | Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E. |
Q34600570 | Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction |
Q34353018 | Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function |
Q33476410 | Monocytes and platelets share the glycoproteins IIb and IIIa that are absent from both cells in Glanzmann's thrombasthenia type I |
Q36232350 | Multiple functional forms of the integrin VLA-2 can be derived from a single alpha 2 cDNA clone: interconversion of forms induced by an anti-beta 1 antibody |
Q36346490 | Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase |
Q39476365 | Nephrotic syndrome: a platelet hyperaggregability state |
Q72745713 | Optimal techniques for the immunocytochemical demonstration of?-thromboglobulin, platelet factor 4, and fibrinogen in the alpha granules of unstimulated platelets |
Q39506588 | Platelet activation in normo- and hyperlipoproteinemias |
Q71234741 | Platelet aggregation is inhibited by phycolectins |
Q33404652 | Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors |
Q36053594 | Platelet glycoprotein IIb/IIIa blockade with tirofiban: effect on aggregation caused by P256, an antibody to human IIb/IIIa receptors |
Q35832156 | Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets |
Q33821754 | Platelets have more than one binding site for von Willebrand factor |
Q41915162 | Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets |
Q24318637 | Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C |
Q41453134 | Redistribution of alpha-granules and their contents in thrombin-stimulated platelets |
Q36211385 | Redistribution of the fibrinogen receptor of human platelets after surface activation |
Q34615338 | Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons |
Q73254326 | Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists |
Q37294912 | Role of fibrinogen alpha and gamma chain sites in platelet aggregation |
Q28118972 | Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia |
Q35056329 | Short form of α9 promotes α9β1 integrin-dependent cell adhesion by modulating the function of the full-length α9 subunit |
Q89554692 | Site-specific phosphorylation regulates the functions of kindlin-3 in a variety of cells |
Q40146427 | Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia |
Q37553472 | Synthesis of analogs of human platelet membrane glycoprotein IIb-IIIa complex by chicken peripheral blood thrombocytes |
Q48089724 | Temperature effects on the activity, shape, and storage of platelets from 13-lined ground squirrels. |
Q43735302 | Temporal aggregate size distributions from simulation of platelet aggregation and disaggregation |
Q42160889 | Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa |
Q33381441 | The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend |
Q37556824 | The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets |
Q42540753 | The effect of oral phenylbutazone on whole blood platelet aggregation in the dog. |
Q35839049 | The effect of upstream platelet-fibrinogen interactions on downstream adhesion and activation |
Q42153397 | The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element |
Q35898379 | The human platelet fibrinogen receptor: clinical and therapeutic significance |
Q42161875 | The inhibition of human platelet function by ganodermic acids |
Q34111783 | The integrin VLA-2 binds echovirus 1 and extracellular matrix ligands by different mechanisms |
Q71270172 | The platelet contacts during aggregation |
Q41517769 | The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering |
Q38156780 | The platelet fibrinogen receptor: from megakaryocyte to the mortuary |
Q41904505 | The role of integrins in the maintenance of endothelial monolayer integrity |
Q34182746 | The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress |
Q36233524 | Thrombin adhesive properties: induction by plasmin and heparan sulfate |
Q36356892 | Thrombin increases expression of fibronectin antigen on the platelet surface |
Q36345711 | Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study |
Q35816269 | Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets |
Q35680201 | Using microcontact printing of fibrinogen to control surface-induced platelet adhesion and activation |
Q40347050 | Vitronectin binds to activated human platelets and plays a role in platelet aggregation |
Q70123739 | [Significance of the endothelium of the vascular wall for maintaining hemostasis] |
Q24301146 | gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors |
Q33478102 | von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease |
Q34574601 | von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia |
Search more.